1. Lung Cancer Fact Sheet. 2022 [cited 2022 May 12]. https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/resource-library/lung-cancer-fact-sheet. p.MsoNormal, li.MsoNormal, div.MsoNormalAvailable from: font-size:11.0ptAvailable from: }a:link, span.MsoHyperlinkAvailable from: }a:visited, span.MsoHyperlinkFollowedAvailable from: font-size:11.0ptAvailable from: mso-ansi-font-size:11.0ptAvailable from: mso-bidi-font-size:11.0ptAvailable from: }div.WordSection1.
2. Cancer facts and figures. 2022 [cited 2022 May 12]. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html.
Accessed 10 May 2022.
3. Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer. 2010;10(11):760–74.
4. Oxnard GR, Lo PC, Nishino M, Dahlberg SE, Lindeman NI, et al. Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions. J Thorac Oncol. 2013;8(2):179–84.
5. Cross DA, Ashton SE, Ghiorghiu S, Eberlein C, Nebhan CA, Spitzler PJ, et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 2014;4(9):1046–61.